154 related articles for article (PubMed ID: 21553236)
1. Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor.
Diniz G; Aktas S; Turedi A; Temir G; Ortac R; Vergin C
Tumour Biol; 2011 Aug; 32(4):761-7. PubMed ID: 21553236
[TBL] [Abstract][Full Text] [Related]
2. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.
Yashima K; Maitra A; Timmons CF; Rogers BB; Pinar H; Shay JW; Gazdar AF
Hum Pathol; 1998 May; 29(5):536-42. PubMed ID: 9596280
[TBL] [Abstract][Full Text] [Related]
3. Expression of Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 in Wilms Tumor.
Ersavaş S; Diniz G; Yildirim HT; Koca Y; Kahraman DS; Ayaz D; Demirağ B
Turk Patoloji Derg; 2016; 32(3):158-63. PubMed ID: 27562389
[TBL] [Abstract][Full Text] [Related]
4. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic value of the Ki-67 in Wilms' tumor: experience with 48 cases.
Jurić I; Pogorelić Z; Kuzmić-Prusac I; Biocić M; Jakovljević G; Stepan J; Zupancić B; Culić S; Kruslin B
Pediatr Surg Int; 2010 May; 26(5):487-93. PubMed ID: 20306058
[TBL] [Abstract][Full Text] [Related]
6. Roles of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha, a lipid metabolism enzyme, in Wilms tumor patients.
Wu X; Feng R; Wang X; Guo F; Liu W
J Cancer Res Ther; 2021 Nov; 17(5):1281-1285. PubMed ID: 34850779
[TBL] [Abstract][Full Text] [Related]
7. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
8. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
9. Autophagy related markers (Beclin-1 and ATG4B) are strongly expressed in Wilms' tumor and correlate with favorable histology.
Guimei M; Eladl MA; Ranade AV; Manzoor S
Histol Histopathol; 2019 Jan; 34(1):47-56. PubMed ID: 29989143
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues.
Poremba C; Scheel C; Hero B; Christiansen H; Schaefer KL; Nakayama Ji; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
J Clin Oncol; 2000 Jul; 18(13):2582-92. PubMed ID: 10893290
[TBL] [Abstract][Full Text] [Related]
11. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.
Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED
J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
15. HER2/neu expression: a predictor for differentiation and survival in children with Wilms tumor.
Ragab SM; Samaka RM; Shams TM
Pathol Oncol Res; 2010 Mar; 16(1):61-7. PubMed ID: 19609744
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Cox-2 expression in Wilms' tumor.
Giordano G; Campanini N; Donofrio V; Bertolini P; Falleti J; Grassani C; Pettinato G
Pathol Res Pract; 2008; 204(12):875-82. PubMed ID: 18752906
[TBL] [Abstract][Full Text] [Related]
17. K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.
Dalpa E; Gourvas V; Soulitzis N; Spandidos DA
Med Oncol; 2017 Jan; 34(1):6. PubMed ID: 27943100
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor.
Sredni ST; de Camargo B; Lopes LF; Teixeira R; Simpson A
Med Pediatr Oncol; 2001 Nov; 37(5):455-8. PubMed ID: 11745874
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis.
Guo F; Zhang LJ; Liu W; Wang G; Liu HY; Wang YL; Ma R; Wu RD
J Pediatr Urol; 2014 Apr; 10(2):317-23. PubMed ID: 24119914
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity and telomerase reverse transciptase (TERT) expression in ameloblastomas.
Kumamoto H; Kinouchi Y; Ooya K
J Oral Pathol Med; 2001 Apr; 30(4):231-6. PubMed ID: 11302243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
